Lupin receives approval from TGA Australia for Tiotropium dry powder
The product will be manufactured at Lupin’s Pithampur facility in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin receives USFDA approval for Chlorpromazine Hydrochloride tablets
This product will be manufactured at Lupin’s Somerset facility in the U.S.
Lupin gets EIR from US FDA for Pithampur Unit-2 facility
The EIR was issued post the last inspection of the facility conducted from March 21-29, 2023
Lupin gets tentative US FDA approval for Dolutegravir Tablets for Oral Suspension
This product will be manufactured at Lupin’s Nagpur facility in India
Lupin receives USD 25 million from AbbVie for successful initiation of Phase 1 clinical studies
Lupin and AbbVie inked the licensing, development, and commercialisation agreement in 2018 for this novel oncology drug to treat…
Lupin gets US FDA approval for Tiotropium dry powder inhaler
This product will be manufactured at Lupin’s Pithampur facility in India
Lupin gets US FDA approval for Diazepam Rectal Gel
It is a generic equivalent of Diastat AcuDialTM Rectal Delivery System, 10 mg and 20 mg, of Bausch Health US
Lupin Diagnostics launches Regional Reference Laboratory in Bengaluru
After establishing presence in Hyderabad, this launch expands footprint in South India
Lupin gets tentative US FDA approval for Valbenazine capsules
Valbenazine is indicated for the treatment of tardive dyskinesia (uncontrollable movement of face, tongue, or other body parts)
Lupin receives EIR from US FDA for its injectable facility in Nagpur
The EIR was issued post the last inspection of the facility conducted from October 17, 2022 to October 29, 2022